193 related articles for article (PubMed ID: 36982443)
1. Vitamin D Status and Psoriatic Arthritis: Association with the Risk for Sacroiliitis and Influence on the Retention Rate of Methotrexate Monotherapy and First Biological Drug Survival-A Retrospective Study.
Rotondo C; Cantatore FP; Cici D; Erroi F; Sciacca S; Rella V; Corrado A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982443
[TBL] [Abstract][Full Text] [Related]
2. Anti-cyclic-citrullinated-protein-antibodies in psoriatic arthritis patients: how autoimmune dysregulation could affect clinical characteristics, retention rate of methotrexate monotherapy and first line biotechnological drug survival. A single center retrospective study.
Rotondo C; Corrado A; Cici D; Berardi S; Cantatore FP
Ther Adv Chronic Dis; 2021; 12():2040622320986722. PubMed ID: 33796242
[TBL] [Abstract][Full Text] [Related]
3. Lower concentration of vitamin D is associated with lower DAS28 and VAS-pain scores in patients with inflammatory rheumatic diseases treated with infliximab: a pilot study.
Miler M; Nikolac Gabaj N; Grazio S; Vahtarić A; Vrtarić A; Grubišić F; Skala Kavanagh H; Doko Vajdić I; Vrkić N
Rheumatol Int; 2020 Sep; 40(9):1455-1461. PubMed ID: 32462255
[TBL] [Abstract][Full Text] [Related]
4. Is vitamin D status relevant to psoriasis and psoriatic arthritis? A retrospective cross-sectional study.
Gamonal SBL; Gamonal ACC; Marques NCV; Brandão MAF; Raposo NRB
Sao Paulo Med J; 2022; 141(3):e2022216. PubMed ID: 36214524
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study.
Urruticoechea-Arana A; Martín-Martínez MA; Castañeda S; Piedra CA; González-Juanatey C; Llorca J; Díaz-Gonzalez F; González-Gay MA;
Arthritis Res Ther; 2015 Aug; 17(1):211. PubMed ID: 26271333
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study.
Lindström U; di Giuseppe D; Exarchou S; Alenius GM; Olofsson T; Klingberg E; Jacobsson L; Askling J; Wallman JK
RMD Open; 2023 May; 9(2):. PubMed ID: 37173095
[TBL] [Abstract][Full Text] [Related]
7. High incidence of disease recurrence after discontinuation of disease-modifying antirheumatic drug treatment in patients with psoriatic arthritis in remission.
Araujo EG; Finzel S; Englbrecht M; Schreiber DA; Faustini F; Hueber A; Nas K; Rech J; Schett G
Ann Rheum Dis; 2015 Apr; 74(4):655-60. PubMed ID: 24336010
[TBL] [Abstract][Full Text] [Related]
8. Treatment patterns and health care costs for patients with psoriatic arthritis on biologic therapy: a retrospective cohort study.
Zhu B; Edson-Heredia E; Gatz JL; Guo J; Shuler CL
Clin Ther; 2013 Sep; 35(9):1376-85. PubMed ID: 23954091
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D status, body composition and glycemic control in Polish adolescents with type 1 diabetes.
Wierzbicka E; Szalecki M; Pludowski P; Jaworski M; Brzozowska A
Minerva Endocrinol; 2016 Dec; 41(4):445-55. PubMed ID: 26982098
[TBL] [Abstract][Full Text] [Related]
10. Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients.
Simon D; Kleyer A; Bayat S; Tascilar K; Kampylafka E; Meinderink T; Schuster L; Petrov R; Liphardt AM; Rech J; Schett G; Hueber AJ
Arthritis Res Ther; 2019 Jul; 21(1):162. PubMed ID: 31269973
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA).
Mulder MLM; Vriezekolk JE; den Broeder N; Mahler EAM; Helliwell PS; van den Hoogen FHJ; den Broeder AA; Wenink MH
Trials; 2020 Feb; 21(1):155. PubMed ID: 32041657
[TBL] [Abstract][Full Text] [Related]
13. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
[TBL] [Abstract][Full Text] [Related]
14. First-line csDMARD monotherapy drug retention in psoriatic arthritis: methotrexate outperforms sulfasalazine.
Jacobs ME; Pouw JN; Welsing P; Radstake TRDJ; Leijten EFA
Rheumatology (Oxford); 2021 Feb; 60(2):780-784. PubMed ID: 32797218
[TBL] [Abstract][Full Text] [Related]
15. Psoriatic arthritis treatment and the risk of herpes zoster.
Zisman D; Bitterman H; Shalom G; Feldhamer I; Comanesther D; Batat E; Greenberg-Dotan S; Cohen S; Cohen AD
Ann Rheum Dis; 2016 Jan; 75(1):131-5. PubMed ID: 25261573
[TBL] [Abstract][Full Text] [Related]
16. Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis.
Jadon DR; Sengupta R; Nightingale A; Lindsay M; Korendowych E; Robinson G; Jobling A; Shaddick G; Bi J; Winchester R; Giles JT; McHugh NJ
Ann Rheum Dis; 2017 Apr; 76(4):701-707. PubMed ID: 27913376
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous Response in Several Domains in Patients with Psoriatic Disease Treated with Etanercept as Monotherapy or in Combination with Conventional Synthetic Disease-modifying Antirheumatic Drugs.
Behrens F; Meier L; Prinz JC; Jobst J; Lippe R; Löschmann PA; Lorenz HM
J Rheumatol; 2018 Jun; 45(6):802-810. PubMed ID: 29606665
[TBL] [Abstract][Full Text] [Related]
19. Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial.
Mease PJ; Gladman DD; Collier DH; Ritchlin CT; Helliwell PS; Liu L; Kricorian G; Chung JB
Arthritis Rheumatol; 2019 Jul; 71(7):1112-1124. PubMed ID: 30747501
[TBL] [Abstract][Full Text] [Related]
20. Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study.
Miele G; Abbadessa G; Cavalla P; Valentino P; Marfia GA; Landi D; Bosa C; Vercellino M; De Martino A; Ponzano M; Lavorgna L; Bonavita S
Mult Scler Relat Disord; 2022 Dec; 68():104395. PubMed ID: 36544324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
